N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours
about
Absence of pathogenic mitochondrial DNA mutations in mouse brain tumorsInfluence of caloric restriction on constitutive expression of NF-κB in an experimental mouse astrocytomaCalorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse.Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model.Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer.Identification of potent and selective glucosylceramide synthase inhibitors from a library of N-alkylated iminosugars.Dietary restriction promotes vessel maturation in a mouse astrocytoma.Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a.Differential effects of energy stress on AMPK phosphorylation and apoptosis in experimental brain tumor and normal brainGlycan antagonists and inhibitors: a fount for drug discovery.Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model.Effect of treatment with baicalein on the intracerebral tumor growth and survival of orthotopic glioma models.Caloric restriction reduces edema and prolongs survival in a mouse glioma model.Therapeutic effects of stem cells and substrate reduction in juvenile Sandhoff mice.Lipidomic profiling links the Fanconi anemia pathway to glycosphingolipid metabolism in head and neck cancer cells.A rationally designed fully human EGFRvIII:CD3-targeted bispecific antibody redirects human T cells to treat patient-derived intracerebral malignant glioma.Thematic Review Series: Sphingolipids.Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1aNontoxic Targeting of Energy Metabolism in Preclinical VM-M3 Experimental Glioblastoma
P2860
Q24811339-3586D000-AD4C-4AAF-A693-6EB7E6178A7CQ28477560-58B92504-AD54-4928-AD59-49EE2C40957EQ34014571-EA55E927-9296-45B9-BF2D-E73D6D04DE5FQ34158731-663D8D34-1FDE-4AC1-BD05-0DE73F441D9AQ34542313-9E9C0CBE-2523-4A50-8846-147EEBD647ECQ34576016-3D8EE5BA-2BA8-4F4D-952A-9138A99258FAQ35181892-9743AA70-9CA3-4EED-BC11-91188FCBBCC9Q35664431-E1DD1569-F7F7-4753-A05E-9B79CFD95C4EQ36558306-D12BA69B-2A6A-47D5-94A7-F55C524C1483Q36678446-0D82D55A-8BDE-40D4-9626-7FAE226538DCQ37027396-60586879-93DF-47EB-85D1-9FDDC63CF52BQ37352779-DD18F4F5-8506-4C8A-8840-38559BEE79FAQ38875742-4E085516-185F-4F56-A198-E7F073A8C775Q39148077-9B08CA60-8ACD-48D3-B384-5B3FEDA3FFC7Q48639806-7DA99825-D28B-49F6-8444-A51D5EE4340EQ52659709-30BDD10F-FE66-48EC-9904-5C015D6A4260Q52716114-08E17891-0ACB-4E97-AE3C-1A51E130A8D3Q56658816-60CD98A8-481F-4025-B667-5E10BFA6B86EQ57818007-027481F1-7998-4771-B793-39890142B482
P2860
N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
N -butyldeoxynojirimycin reduc ...... perimental mouse brain tumours
@ast
N -butyldeoxynojirimycin reduc ...... perimental mouse brain tumours
@en
N -butyldeoxynojirimycin reduc ...... perimental mouse brain tumours
@nl
type
label
N -butyldeoxynojirimycin reduc ...... perimental mouse brain tumours
@ast
N -butyldeoxynojirimycin reduc ...... perimental mouse brain tumours
@en
N -butyldeoxynojirimycin reduc ...... perimental mouse brain tumours
@nl
prefLabel
N -butyldeoxynojirimycin reduc ...... perimental mouse brain tumours
@ast
N -butyldeoxynojirimycin reduc ...... perimental mouse brain tumours
@en
N -butyldeoxynojirimycin reduc ...... perimental mouse brain tumours
@nl
P2093
P2860
P356
P1476
N -butyldeoxynojirimycin reduc ...... perimental mouse brain tumours
@en
P2093
M El-Abbadi
M G Manfredi
P Mukherjee
T N Seyfried
P2860
P2888
P304
P356
10.1054/BJOC.2000.1713
P407
P577
2001-04-20T00:00:00Z
P5875
P6179
1043072172